Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Cleaning After Batch Failure – V 2.0

Posted on By

Elixir Department: SOP for Cleaning After Batch Failure – V 2.0

Standard Operating Procedure for Cleaning After Batch Failure in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/186/2025
Supersedes SOP/ELX/186/2022
Page No. Page 1 of 10
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To outline a comprehensive and risk-controlled procedure for cleaning of equipment, areas, and accessories following a batch failure during elixir manufacturing, ensuring complete removal of residues and preventing cross-contamination.

2. Scope

This SOP applies to all equipment, utensils, pipelines, and related surfaces used during failed or rejected batches of elixirs in the Elixir Manufacturing Department.

3. Responsibilities

  • Production Operator:
    • Perform initial segregation and cleaning activities post-failure.
  • Production Supervisor:
    • Initiate cleaning protocol and inform QA and Engineering.
  • QA Officer:
    • Verify cleaning effectiveness and approve equipment for reuse.
  • Engineering Department:
    • Support equipment disassembly and cleaning in case of residue adherence or operational issues.
See also  Elixir Department: SOP for Titration of pH Buffers - V 2.0

4. Accountability

The Production Head is accountable for executing the cleaning process after batch failure. QA Head is responsible for verification, compliance, and documentation of the entire process.

5. Procedure

5.1 Initiation

  1. Immediately inform
QA, Engineering, and Production Head upon confirmation of batch failure.
  • Segregate the failed batch material and transfer to a designated area with “REJECTED – HOLD FOR DISPOSAL” label.
  • Quarantine the equipment used until cleaning is completed and verified.
  • 5.2 Risk Assessment

    1. QA to perform a risk assessment based on:
      • Nature of failure (e.g., microbial contamination, physical non-conformity, chemical incompatibility)
      • Solubility and stickiness of the product
      • Contamination potential
    2. Determine whether routine or intensified cleaning is required.

    5.3 Cleaning Execution

    1. Drain all process lines and rinse with purified water to remove bulk residue.
    2. Apply 1–2% validated detergent solution and manually scrub product-contact surfaces.
    3. Perform multiple rinses with purified water until rinse water meets conductivity/pH acceptance criteria.
    4. If product was alcohol-based, use appropriate solvent flush or hot water as per cleaning validation.
    5. Inspect and clean auxiliary parts like valves, nozzles, gaskets, and transfer pipes.

    5.4 Verification and Documentation

    1. QA to visually inspect for residual material, stains, or odor.
    2. If required, collect swab or rinse samples for analytical testing as per validation protocol.
    3. Document cleaning activity in the Batch Failure Cleaning Logbook (Annexure-1).
    4. Equipment to be marked as “CLEANED – READY FOR USE” only after QA approval.

    5.5 Reassembly and Clearance

    1. Engineering to support reassembly of any disassembled parts.
    2. Conduct air drying or hot air cabinet drying as per SOP/ELX/185/2025.
    3. Final clearance given by QA to Production before use in subsequent batch.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • CIP: Clean-In-Place

    7. Documents

    1. Batch Failure Cleaning Logbook (Annexure-1)
    2. Cleaning Verification Report
    3. Deviation/Non-Conformance Report

    8. References

    • 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
    • ICH Q7 – GMP for Active Pharmaceutical Ingredients
    • WHO TRS 986 – GMP Annex 4: Cleaning Validation

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Batch Failure Cleaning Logbook

    Date Batch No. Equipment ID Cleaning Performed By QA Verified By Remarks
    11/04/2025 ELX-0425-007 MXR-ELX-06 Rajesh Kumar Sunita Reddy Visually Cleaned – Swab Results Pending

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Added risk assessment and sampling clause Regulatory Compliance QA Head
    See also  Elixir Department: SOP for Homogeneity Verification - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Outdated Site Master File Presented During Inspection: A GMP Readiness Concern
    Next Post: Gel Manufacturing: SOP for Managing Breakdowns of Gel Manufacturing Equipment – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version